SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-01-25 11:27
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Springer, Barry Alan
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,600
+20,000 vol
$1.48 each
60,000
Filed 2024-01-25 11:26
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Buyse, Chris
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,600
+20,000 vol
$1.48 each
60,000
Filed 2024-01-25 11:25
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,600
+20,000 vol
$1.48 each
60,000
Filed 2024-01-25 11:23
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,600
+20,000 vol
$1.48 each
60,000
Filed 2024-01-25 11:08
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$59,200
+40,000 vol
$1.48 each
40,000
Filed 2024-01-25 11:07
Tx date 2023-11-09
$IPA
ImmunoPrecise Antibodies Ltd.
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 11:05
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Buyse, Chris
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$59,200
+40,000 vol
$1.48 each
40,000
Filed 2024-01-25 11:04
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Buyse, Chris
4 - Director of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 11:00
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Springer, Barry Alan
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$59,200
+40,000 vol
$1.48 each
40,000
Filed 2024-01-25 10:59
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Springer, Barry Alan
4 - Director of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-25 10:55
Tx date 2024-01-19
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$59,200
+40,000 vol
$1.48 each
40,000
Filed 2024-01-25 10:39
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-09 11:59
Tx date 2023-12-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$20,000
+20,000 vol
$1.00 each
225,818
Filed 2023-12-27 11:19
Tx date 2023-12-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,000
+20,000 vol
$1.00 each
Filed 2023-12-27 11:19
Tx date 2023-12-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,000
+20,000 vol
$1.00 each
225,818
Filed 2023-12-21 09:39
Tx date 2023-12-20
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,698
+2,000 vol
$1.35 each
207,818
Filed 2023-12-20 10:17
Tx date 2023-12-18
$IPA
ImmunoPrecise Antibodies Ltd.
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,834
+10,000 vol
$1.38 each
10,000
Filed 2023-12-20 10:15
Tx date 2023-11-09
$IPA
ImmunoPrecise Antibodies Ltd.
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-11-13 05:48
Tx date 2023-11-09
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,700
+1,000 vol
$1.70 each
1,950
Filed 2023-11-03 13:54
Tx date 2023-11-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,066
+1,000 vol
$2.07 each
205,818
Filed 2023-10-31 06:39
Tx date 2023-10-27
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,729
+950 vol
$1.82 each
950
Filed 2023-10-26 15:05
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,115
+900 vol
$1.24 each
204,818
Filed 2023-10-26 15:03
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
203,918
Filed 2023-10-26 15:02
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.10
+100 vol
$1.23 each
203,818
Filed 2023-10-26 15:01
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
203,718
Filed 2023-10-26 15:00
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
203,618
Filed 2023-10-26 15:00
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$246.00
+200 vol
$1.23 each
203,518
Filed 2023-10-26 14:58
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
203,118
Filed 2023-10-26 14:56
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
203,018
Filed 2023-10-26 14:55
Tx date 2023-10-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$123.00
+100 vol
$1.23 each
202,918
Filed 2023-10-26 12:51
Tx date 2023-10-26
$IPA
ImmunoPrecise Antibodies Ltd.
Taylor, Kristin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,750
+5,000 vol
$1.35 each
5,000
Filed 2023-10-26 12:50
Tx date 2023-09-18
$IPA
ImmunoPrecise Antibodies Ltd.
Taylor, Kristin
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-10-26 10:19
Tx date 2023-10-25
$IPA
ImmunoPrecise Antibodies Ltd.
Springer, Barry Alan
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,090
+10,000 vol
$1.41 each
10,000
Filed 2023-10-19 11:48
Tx date 2023-10-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,320
+1,000 vol
$1.32 each
202,818
Filed 2023-10-03 14:23
Tx date 2023-10-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$176.00
+100 vol
$1.76 each
3,942
Filed 2023-10-03 14:23
Tx date 2023-10-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$184.80
+105 vol
$1.76 each
3,842
Filed 2023-10-03 14:22
Tx date 2023-10-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$600.16
+341 vol
$1.76 each
3,737
Filed 2023-10-03 14:22
Tx date 2023-10-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10.56
+6 vol
$1.76 each
3,396
Filed 2023-10-03 14:21
Tx date 2023-10-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$84.48
+48 vol
$1.76 each
3,390
Filed 2023-09-25 09:44
Tx date 2023-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,980
+1,000 vol
$1.98 each
201,818
Filed 2023-09-18 11:25
Tx date 2023-09-18
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,890
+1,000 vol
$1.89 each
200,818
Filed 2023-09-13 15:49
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Springer, Barry Alan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 15:33
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Witters, Dirk
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 15:09
Tx date 2023-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Buyse, Chris
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-01 14:57
Tx date 2023-05-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$298.27
+100 vol
$2.98 each
199,818
Filed 2023-06-01 14:56
Tx date 2023-05-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,516
+850 vol
$2.96 each
199,718
Filed 2023-04-20 11:05
Tx date 2023-04-20
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,800
+1,000 vol
$2.80 each
27,209
Filed 2023-04-06 14:06
Tx date 2023-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,960
+2,000 vol
$2.48 each
26,209
Filed 2023-04-04 14:27
Tx date 2023-04-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$516.00
+200 vol
$2.58 each
198,868
Filed 2023-04-04 14:26
Tx date 2023-04-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$518.00
+200 vol
$2.59 each
198,668
Filed 2023-04-04 14:24
Tx date 2023-04-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$633.60
+240 vol
$2.64 each
198,468
Filed 2023-04-03 09:12
Tx date 2023-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,872
+1,000 vol
$2.87 each
198,228
Filed 2023-04-03 09:11
Tx date 2023-03-28
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-111,400
-40,000 vol
$2.79 each
20,370
Filed 2023-03-28 10:08
Tx date 2023-03-27
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$672.75
+230 vol
$2.92 each
197,228
Filed 2023-03-28 10:07
Tx date 2023-03-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,251
+400 vol
$3.13 each
196,998
Filed 2023-03-28 10:07
Tx date 2023-03-20
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$334.00
+100 vol
$3.34 each
196,598
Filed 2023-03-23 14:06
Tx date 2023-03-17
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$974.91
+300 vol
$3.25 each
25,500
Filed 2023-03-23 14:06
Tx date 2023-03-17
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$648.02
+200 vol
$3.24 each
25,200
Filed 2023-03-21 16:12
Tx date 2023-03-21
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,808
+605 vol
$2.99 each
24,209
Filed 2023-03-21 16:11
Tx date 2023-03-21
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,177
+395 vol
$2.98 each
23,604
Filed 2023-03-20 14:35
Tx date 2023-03-20
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,220
+1,000 vol
$3.22 each
23,209
Filed 2023-03-20 10:05
Tx date 2023-03-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$968.46
+300 vol
$3.23 each
196,498
Filed 2023-03-20 10:04
Tx date 2023-03-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$650.00
+200 vol
$3.25 each
196,198
Filed 2023-03-20 10:02
Tx date 2023-03-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$482.89
+150 vol
$3.22 each
195,998
Filed 2023-02-26 01:14
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$245,999
+60,000 vol
$4.10 each
102,000
Filed 2023-02-26 01:12
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$164,000
+40,000 vol
$4.10 each
105,000
Filed 2023-02-26 01:10
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$1,231,853
+300,452 vol
$4.10 each
700,452
Filed 2023-02-26 01:08
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$204,999
+50,000 vol
$4.10 each
77,000
Filed 2023-02-26 01:06
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$1,231,853
+300,452 vol
$4.10 each
Filed 2023-02-24 09:45
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,786
+7,265 vol
$4.10 each
112,265
Filed 2023-02-24 09:36
Tx date 2023-02-19
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$29,786
+7,265 vol
$4.10 each
52,265
Filed 2023-02-23 17:15
Tx date 2022-12-13
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
105,000
Filed 2023-02-23 17:13
Tx date 2022-12-13
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,000
Filed 2023-02-22 23:13
Tx date 2023-02-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$483.00
+120 vol
$4.03 each
195,848
Filed 2023-02-22 23:12
Tx date 2023-02-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$408.00
+100 vol
$4.08 each
195,728
Filed 2023-02-10 23:59
Tx date 2023-02-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$199,308
+84,812 vol
$2.35 each
195,628
Filed 2023-02-10 23:59
Tx date 2023-02-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options
$-329,000
-140,000 vol
$2.35 each
400,000
Filed 2023-02-10 23:53
Tx date 2023-02-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$199,308
+84,812 vol
$2.35 each
Filed 2023-02-10 23:51
Tx date 2023-02-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$199,308
+84,812 vol
$2.35 each
Filed 2023-01-04 12:41
Tx date 2023-01-03
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$97,500
+30,000 vol
$3.25 each
72,500
Filed 2023-01-04 12:40
Tx date 2023-01-03
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options
$-97,500
-30,000 vol
$3.25 each
15,000
Filed 2022-12-19 10:24
Tx date 2022-12-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,401
+490 vol
$4.90 each
110,816
Filed 2022-12-19 10:23
Tx date 2022-12-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,550
+510 vol
$5.00 each
110,326
Filed 2022-12-19 10:21
Tx date 2022-12-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,915
+1,000 vol
$4.92 each
109,816
Filed 2022-11-08 11:53
Tx date 2022-11-04
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$966.00
+200 vol
$4.83 each
108,816
Filed 2022-11-08 11:52
Tx date 2022-11-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$471.00
+100 vol
$4.71 each
108,616
Filed 2022-11-08 11:52
Tx date 2022-11-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$473.00
+100 vol
$4.73 each
108,516
Filed 2022-11-08 10:55
Tx date 2022-11-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$966.00
+200 vol
$4.83 each
108,816
Filed 2022-11-08 10:55
Tx date 2022-11-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$966.00
+200 vol
$4.83 each
Filed 2022-11-08 10:54
Tx date 2022-11-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$471.00
+100 vol
$4.71 each
Filed 2022-11-08 10:54
Tx date 2022-11-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$471.00
+100 vol
$4.71 each
108,616
Filed 2022-11-08 10:53
Tx date 2022-11-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$473.00
+100 vol
$4.73 each
108,516
Filed 2022-11-08 10:53
Tx date 2022-11-07
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$473.00
+100 vol
$4.73 each
Filed 2022-10-31 09:57
Tx date 2022-10-19
$IPA
ImmunoPrecise Antibodies Ltd.
Vézina, Sébastien
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-10-06 12:51
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$783.82
+200 vol
$3.92 each
108,416
Filed 2022-10-06 12:46
Tx date 2022-09-28
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$391.00
+100 vol
$3.91 each
107,016
Filed 2022-10-06 12:43
Tx date 2022-09-27
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,454
+600 vol
$4.09 each
106,916
Filed 2022-10-06 12:43
Tx date 2022-09-27
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,636
+400 vol
$4.09 each
106,316
Filed 2022-10-06 12:42
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$783.82
+200 vol
$3.92 each
Filed 2022-10-06 12:42
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$389.00
+100 vol
$3.89 each
108,216
Filed 2022-10-06 12:41
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$388.90
+100 vol
$3.89 each
108,116
Filed 2022-10-06 12:41
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$385.00
+100 vol
$3.85 each
108,016
Filed 2022-10-06 12:40
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$388.27
+100 vol
$3.88 each
107,916
Filed 2022-10-06 12:40
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,166
+300 vol
$3.89 each
107,816
Filed 2022-10-06 12:39
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,156
+300 vol
$3.85 each
107,516
Filed 2022-10-06 12:38
Tx date 2022-09-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$789.80
+200 vol
$3.95 each
107,216
Filed 2022-09-26 11:03
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$72.00
+18 vol
$4.00 each
105,916
Filed 2022-09-26 11:02
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$992.20
+242 vol
$4.10 each
105,898
Filed 2022-09-26 11:02
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$237.80
+58 vol
$4.10 each
105,656
Filed 2022-09-26 11:01
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$410.00
+100 vol
$4.10 each
105,598
Filed 2022-09-26 11:01
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$410.00
+100 vol
$4.10 each
105,498
Filed 2022-09-26 11:00
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$891.00
+220 vol
$4.05 each
105,398
Filed 2022-09-26 11:00
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,134
+280 vol
$4.05 each
105,178
Filed 2022-09-26 10:59
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$420.00
+100 vol
$4.20 each
104,898
Filed 2022-09-26 10:59
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,980
+1,900 vol
$4.20 each
104,798
Filed 2022-09-26 10:58
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,315
+1,000 vol
$4.32 each
102,898
Filed 2022-09-26 10:56
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,182
+500 vol
$4.36 each
101,898
Filed 2022-09-26 09:56
Tx date 2022-09-20
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$503.05
+100 vol
$5.03 each
98,098
Filed 2022-09-26 09:56
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$149.76
+32 vol
$4.68 each
101,398
Filed 2022-09-26 09:55
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$318.24
+68 vol
$4.68 each
101,366
Filed 2022-09-26 09:55
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$459.99
+100 vol
$4.60 each
101,298
Filed 2022-09-26 09:54
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$395.59
+86 vol
$4.60 each
101,198
Filed 2022-09-26 09:54
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,456
+314 vol
$4.64 each
101,112
Filed 2022-09-26 09:53
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,314
+500 vol
$4.63 each
100,798
Filed 2022-09-26 09:53
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,277
+500 vol
$4.55 each
100,298
Filed 2022-09-26 09:52
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$458.90
+100 vol
$4.59 each
99,798
Filed 2022-09-26 09:52
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$458.97
+100 vol
$4.59 each
99,698
Filed 2022-09-26 09:51
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$459.00
+100 vol
$4.59 each
99,598
Filed 2022-09-26 09:51
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$459.00
+100 vol
$4.59 each
99,498
Filed 2022-09-26 09:50
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$459.00
+100 vol
$4.59 each
99,398
Filed 2022-09-26 09:50
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,327
+500 vol
$4.65 each
99,298
Filed 2022-09-26 09:49
Tx date 2022-09-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,329
+500 vol
$4.66 each
98,798
Filed 2022-09-26 09:48
Tx date 2022-09-21
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$500.00
+100 vol
$5.00 each
98,298
Filed 2022-09-26 09:47
Tx date 2022-09-21
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$503.34
+100 vol
$5.03 each
98,198
Filed 2022-09-23 15:51
Tx date 2022-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,935
+3,500 vol
$5.41 each
42,500
Filed 2022-09-16 11:02
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,456
+300 vol
$4.85 each
97,998
Filed 2022-09-16 11:02
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,489
+500 vol
$4.98 each
97,698
Filed 2022-09-16 11:01
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,486
+300 vol
$4.96 each
97,198
Filed 2022-09-16 11:01
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$279.87
+57 vol
$4.91 each
96,898
Filed 2022-09-16 11:01
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$702.13
+143 vol
$4.91 each
96,841
Filed 2022-09-16 11:00
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$493.00
+100 vol
$4.93 each
96,698
Filed 2022-09-16 11:00
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$493.00
+100 vol
$4.93 each
96,598
Filed 2022-09-16 10:59
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$746.64
+153 vol
$4.88 each
96,498
Filed 2022-09-16 10:59
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$229.36
+47 vol
$4.88 each
96,345
Filed 2022-09-16 10:58
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$863.76
+177 vol
$4.88 each
96,298
Filed 2022-09-16 10:58
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$112.24
+23 vol
$4.88 each
96,121
Filed 2022-09-16 10:57
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$976.00
+200 vol
$4.88 each
96,098
Filed 2022-09-16 10:57
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$499.00
+100 vol
$4.99 each
95,898
Filed 2022-09-16 10:56
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$844.98
+169 vol
$5.00 each
95,798
Filed 2022-09-16 10:56
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,434
+687 vol
$5.00 each
95,629
Filed 2022-09-16 10:55
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$220.00
+44 vol
$5.00 each
94,942
Filed 2022-09-16 09:02
Tx date 2022-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,902
+4,000 vol
$4.98 each
8,000
Filed 2022-08-18 16:24
Tx date 2022-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,915
+500 vol
$5.83 each
94,898
Filed 2022-08-18 16:23
Tx date 2022-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,149
+200 vol
$5.75 each
94,398
Filed 2022-08-18 16:23
Tx date 2022-08-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,085
+200 vol
$5.43 each
94,198
Filed 2022-08-18 16:22
Tx date 2022-08-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,074
+200 vol
$5.37 each
93,998
Filed 2022-08-18 08:56
Tx date 2022-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,310
+1,000 vol
$7.31 each
31,000
Filed 2022-08-16 14:44
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$479.50
+100 vol
$4.79 each
90,698
Filed 2022-08-16 14:43
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$479.50
+100 vol
$4.79 each
90,598
Filed 2022-08-16 14:43
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$479.50
+100 vol
$4.79 each
90,498
Filed 2022-08-16 14:42
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$479.50
+100 vol
$4.79 each
90,398
Filed 2022-08-16 14:41
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$484.00
+100 vol
$4.84 each
90,298
Filed 2022-08-16 14:41
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$484.00
+100 vol
$4.84 each
90,198
Filed 2022-08-16 14:41
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,407
+500 vol
$4.82 each
90,098
Filed 2022-08-16 14:40
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,420
+296 vol
$4.80 each
89,598
Filed 2022-08-16 14:39
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$979.20
+204 vol
$4.80 each
89,302
Filed 2022-08-16 14:39
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,463
+300 vol
$4.88 each
89,098
Filed 2022-08-16 14:38
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,410
+800 vol
$5.51 each
93,298
Filed 2022-08-16 14:38
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,096
+200 vol
$5.48 each
92,498
Filed 2022-08-16 14:37
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$549.99
+100 vol
$5.50 each
92,298
Filed 2022-08-16 14:37
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$550.00
+100 vol
$5.50 each
92,198
Filed 2022-08-16 14:36
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$66.00
+12 vol
$5.50 each
92,098
Filed 2022-08-16 14:36
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$484.00
+88 vol
$5.50 each
92,086
Filed 2022-08-16 14:35
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,668
+300 vol
$5.56 each
91,998
Filed 2022-08-16 14:35
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,347
+600 vol
$5.58 each
91,698
Filed 2022-08-16 14:34
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,210
+400 vol
$5.53 each
91,098
Filed 2022-08-16 14:33
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$529.50
+100 vol
$5.29 each
93,798
Filed 2022-08-16 14:32
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$534.10
+100 vol
$5.34 each
93,698
Filed 2022-08-16 14:31
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,071
+200 vol
$5.36 each
93,598
Filed 2022-08-16 14:30
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$545.56
+100 vol
$5.46 each
93,398
Filed 2022-08-15 19:06
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,670
+5,000 vol
$6.93 each
39,000
Filed 2022-08-15 16:09
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$692.00
+100 vol
$6.92 each
60,370
Filed 2022-08-15 16:08
Tx date 2022-08-15
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,744
+400 vol
$6.86 each
60,270
Filed 2022-08-12 14:19
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$718.00
+100 vol
$7.18 each
59,870
Filed 2022-08-12 14:18
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$719.00
+100 vol
$7.19 each
59,770
Filed 2022-08-12 14:18
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,157
+300 vol
$7.19 each
59,670
Filed 2022-08-12 14:18
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$719.00
+100 vol
$7.19 each
59,370
Filed 2022-08-12 14:17
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$718.00
+100 vol
$7.18 each
59,270
Filed 2022-08-12 14:17
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$717.00
+100 vol
$7.17 each
59,170
Filed 2022-08-12 14:17
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$716.00
+100 vol
$7.16 each
59,070
Filed 2022-08-12 14:16
Tx date 2022-08-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,420
+200 vol
$7.10 each
58,970
Filed 2022-08-12 14:15
Tx date 2022-08-11
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$651.00
+100 vol
$6.51 each
58,770
Filed 2022-08-12 14:15
Tx date 2022-08-11
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,208
+800 vol
$6.51 each
58,670
Filed 2022-08-11 10:07
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$435.21
+100 vol
$4.35 each
88,798
Filed 2022-08-11 10:06
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,304
+300 vol
$4.35 each
88,698
Filed 2022-08-11 10:05
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,686
+400 vol
$4.22 each
88,398
Filed 2022-08-11 10:04
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,224
+295 vol
$4.15 each
87,998
Filed 2022-08-11 10:03
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20.95
+5 vol
$4.19 each
87,703
Filed 2022-08-10 11:46
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$575.00
+100 vol
$5.75 each
57,870
Filed 2022-08-10 11:46
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,300
+400 vol
$5.75 each
57,770
Filed 2022-08-10 11:45
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,592
+800 vol
$5.74 each
57,370
Filed 2022-08-10 11:45
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,450
+600 vol
$5.75 each
56,570
Filed 2022-08-10 11:44
Tx date 2022-08-10
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,980
+1,400 vol
$5.70 each
55,970
Filed 2022-08-10 11:05
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$550.00
+100 vol
$5.50 each
54,570
Filed 2022-08-10 11:05
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$550.00
+100 vol
$5.50 each
54,470
Filed 2022-08-10 11:04
Tx date 2022-08-09
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,750
+500 vol
$5.50 each
54,370
Filed 2022-08-08 09:50
Tx date 2022-08-04
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$816.00
+200 vol
$4.08 each
87,348
Filed 2022-08-08 09:49
Tx date 2022-08-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$607.50
+150 vol
$4.05 each
87,698
Filed 2022-08-08 09:49
Tx date 2022-08-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$403.23
+100 vol
$4.03 each
87,548
Filed 2022-08-08 09:48
Tx date 2022-08-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$402.50
+100 vol
$4.03 each
87,448
Filed 2022-08-04 11:40
Tx date 2022-08-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,604
+400 vol
$4.01 each
87,148
Filed 2022-08-04 11:39
Tx date 2022-08-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$796.00
+200 vol
$3.98 each
86,748
Filed 2022-08-04 11:39
Tx date 2022-08-03
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,009
+500 vol
$4.02 each
86,548
Filed 2022-08-04 11:38
Tx date 2022-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,660
+400 vol
$4.15 each
86,048
Filed 2022-08-04 11:37
Tx date 2022-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,269
+300 vol
$4.23 each
85,648
Filed 2022-08-04 11:36
Tx date 2022-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,275
+300 vol
$4.25 each
85,348
Filed 2022-08-04 11:35
Tx date 2022-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$425.00
+100 vol
$4.25 each
85,048
Filed 2022-08-04 11:35
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8.98
+2 vol
$4.49 each
84,948
Filed 2022-08-04 11:34
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$360.80
+88 vol
$4.10 each
84,946
Filed 2022-08-01 14:36
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$433.00
+100 vol
$4.33 each
3,342
Filed 2022-08-01 14:36
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$385.84
+91 vol
$4.24 each
3,242
Filed 2022-08-01 14:35
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$65.10
+15 vol
$4.34 each
3,151
Filed 2022-08-01 14:34
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$391.98
+94 vol
$4.17 each
3,136
Filed 2022-08-01 14:34
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,480
+2,000 vol
$4.24 each
3,042
Filed 2022-08-01 14:33
Tx date 2022-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$434.00
+100 vol
$4.34 each
1,042
Filed 2022-06-09 15:41
Tx date 2022-06-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
36 - Conversion or exchange

-$35,000 vol
$0
Filed 2022-06-09 15:23
Tx date 2022-06-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$174,998
+41,176 vol
$4.25 each
84,858
Filed 2022-06-09 15:00
Tx date 2022-06-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$174,998
+41,176 vol
$4.25 each
Filed 2022-05-25 13:58
Tx date 2022-05-25
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Convertible Debentures
36 - Conversion or exchange

-$50,000 vol
$0
Filed 2022-05-25 13:56
Tx date 2022-05-25
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
36 - Conversion or exchange
$49,997
+11,764 vol
$4.25 each
22,209
Filed 2022-05-12 16:50
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,400
+900 vol
$6.00 each
53,870
Filed 2022-05-12 16:49
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,436
+900 vol
$6.04 each
52,970
Filed 2022-05-12 16:47
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,210
+200 vol
$6.05 each
52,070
Filed 2022-05-12 16:44
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,550
+1,500 vol
$5.70 each
51,870
Filed 2022-05-12 16:44
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$569.00
+100 vol
$5.69 each
50,370
Filed 2022-05-12 16:42
Tx date 2022-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,952
+1,400 vol
$5.68 each
50,270
Filed 2022-05-12 09:26
Tx date 2022-05-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$221.50
+50 vol
$4.43 each
43,682
Filed 2022-05-11 09:27
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$466.50
+100 vol
$4.67 each
43,632
Filed 2022-05-11 09:26
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,820
+600 vol
$4.70 each
43,532
Filed 2022-05-11 09:26
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$958.00
+200 vol
$4.79 each
42,932
Filed 2022-05-11 09:25
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$479.00
+100 vol
$4.79 each
42,732
Filed 2022-05-11 09:24
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4.80
+1 vol
$4.80 each
42,632
Filed 2022-05-11 09:24
Tx date 2022-05-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,435
+299 vol
$4.80 each
42,631
Filed 2022-05-09 10:28
Tx date 2022-05-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$542.00
+100 vol
$5.42 each
42,332
Filed 2022-05-09 10:27
Tx date 2022-05-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$352.79
+63 vol
$5.60 each
42,232
Filed 2022-05-09 10:26
Tx date 2022-05-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$336.00
+60 vol
$5.60 each
42,169
Filed 2022-05-09 10:25
Tx date 2022-05-05
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$332.10
+60 vol
$5.54 each
42,109
Filed 2022-05-09 10:22
Tx date 2022-05-04
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$507.85
+90 vol
$5.64 each
42,049
Filed 2022-05-03 11:47
Tx date 2022-04-28
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$418.52
+75 vol
$5.58 each
41,659
Filed 2022-05-03 11:45
Tx date 2022-04-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$556.96
+100 vol
$5.57 each
41,959
Filed 2022-05-03 11:44
Tx date 2022-04-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$554.33
+100 vol
$5.54 each
41,859
Filed 2022-05-03 11:43
Tx date 2022-04-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$553.00
+100 vol
$5.53 each
41,759
Filed 2022-05-03 11:42
Tx date 2022-04-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$418.52
+75 vol
$5.58 each
Filed 2022-04-27 23:01
Tx date 2022-04-27
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,395
+250 vol
$5.58 each
41,584
Filed 2022-04-25 10:34
Tx date 2022-04-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,855
+500 vol
$5.71 each
41,334
Filed 2022-04-25 10:34
Tx date 2022-04-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$565.00
+100 vol
$5.65 each
40,834
Filed 2022-04-25 10:33
Tx date 2022-04-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$750.10
+130 vol
$5.77 each
40,734
Filed 2022-04-25 10:33
Tx date 2022-04-22
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$572.00
+100 vol
$5.72 each
40,604
Filed 2022-04-18 11:07
Tx date 2022-04-13
$IPA
ImmunoPrecise Antibodies Ltd.
Van Hyfte, Dirk Medard Helena
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charmquark EEN (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$8,553,850
+1,565,865 vol
$5.46 each
1,565,865
Filed 2022-04-18 11:06
Tx date 2022-04-13
$IPA
ImmunoPrecise Antibodies Ltd.
Van Hyfte, Dirk Medard Helena
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charmquark EEN (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-18 11:05
Tx date 2022-04-13
$IPA
ImmunoPrecise Antibodies Ltd.
Brands, Ingrid Maria Henri
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charmquark TWEE (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$8,553,850
+1,565,865 vol
$5.46 each
1,565,865
Filed 2022-04-18 10:59
Tx date 2022-04-13
$IPA
ImmunoPrecise Antibodies Ltd.
Brands, Ingrid Maria Henri
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charmquark TWEE (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-14 16:19
Tx date 2022-04-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,689
+300 vol
$5.63 each
40,504
Filed 2022-04-14 16:18
Tx date 2022-04-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$570.00
+100 vol
$5.70 each
40,204
Filed 2022-04-14 16:18
Tx date 2022-04-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,740
+300 vol
$5.80 each
40,104
Filed 2022-04-14 16:18
Tx date 2022-04-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$583.36
+100 vol
$5.83 each
39,804
Filed 2022-04-14 16:15
Tx date 2022-04-14
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$36,250
+5,000 vol
$7.25 each
48,870
Filed 2022-04-13 14:51
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,767
+300 vol
$5.89 each
39,704
Filed 2022-04-11 14:59
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,758
+300 vol
$5.86 each
39,404
Filed 2022-04-11 14:58
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,152
+200 vol
$5.76 each
39,104
Filed 2022-04-11 14:58
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,461
+600 vol
$5.77 each
38,904
Filed 2022-04-11 14:53
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$53,290
+7,300 vol
$7.30 each
43,870
Filed 2022-04-11 14:53
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$18,954
+2,700 vol
$7.02 each
36,570
Filed 2022-04-11 12:01
Tx date 2022-04-11
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,388
+942 vol
$5.72 each
942
Filed 2022-04-11 12:00
Tx date 2021-06-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-10 01:32
Tx date 2022-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Dahl, Carla Cherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$59,900
+10,000 vol
$5.99 each
10,000
Filed 2022-04-10 01:31
Tx date 2021-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Dahl, Carla Cherry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-04-08 09:29
Tx date 2022-04-07
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$695.00
+100 vol
$6.95 each
1,200
Filed 2022-04-08 09:29
Tx date 2022-04-07
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,200
+600 vol
$7.00 each
1,100
Filed 2022-04-06 21:45
Tx date 2022-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,207
+390 vol
$5.66 each
38,304
Filed 2022-04-06 21:45
Tx date 2022-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,825
+500 vol
$5.65 each
37,914
Filed 2022-04-06 21:44
Tx date 2022-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$575.00
+100 vol
$5.75 each
37,414
Filed 2022-04-06 21:44
Tx date 2022-04-06
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,722
+300 vol
$5.74 each
37,314
Filed 2022-04-05 12:57
Tx date 2022-04-05
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,470
+3,000 vol
$7.49 each
34,000
Filed 2022-04-05 02:07
Tx date 2022-04-04
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,363
+900 vol
$7.07 each
33,870
Filed 2022-04-05 02:06
Tx date 2022-04-04
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$60,200
+8,600 vol
$7.00 each
32,970
Filed 2022-04-05 02:06
Tx date 2022-04-04
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,796
+400 vol
$6.99 each
24,370
Filed 2022-04-03 19:40
Tx date 2022-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$674.70
+130 vol
$5.19 each
37,014
Filed 2022-04-03 19:40
Tx date 2022-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,545
+300 vol
$5.15 each
36,884
Filed 2022-04-03 19:39
Tx date 2022-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$505.00
+100 vol
$5.05 each
36,584
Filed 2022-04-01 14:57
Tx date 2022-03-31
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,491
+300 vol
$4.97 each
36,484
Filed 2022-04-01 14:57
Tx date 2022-03-31
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$504.00
+100 vol
$5.04 each
36,184
Filed 2022-04-01 14:56
Tx date 2022-03-31
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$514.00
+100 vol
$5.14 each
36,084
Filed 2022-04-01 12:42
Tx date 2022-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,232
+800 vol
$5.29 each
4,000
Filed 2022-04-01 12:41
Tx date 2022-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,056
+200 vol
$5.28 each
3,200
Filed 2022-03-31 11:55
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,497
+300 vol
$4.99 each
35,984
Filed 2022-03-31 11:55
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$492.00
+100 vol
$4.92 each
35,684
Filed 2022-03-31 11:54
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,318
+1,300 vol
$4.86 each
35,584
Filed 2022-03-31 11:54
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,910
+600 vol
$4.85 each
34,284
Filed 2022-03-31 11:53
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,006
+1,300 vol
$4.62 each
33,684
Filed 2022-03-31 10:11
Tx date 2022-03-31
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,970
+3,000 vol
$4.99 each
3,000
Filed 2022-03-31 10:10
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-30 17:29
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,898
+2,600 vol
$5.73 each
23,970
Filed 2022-03-30 17:28
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,018
+700 vol
$5.74 each
21,370
Filed 2022-03-30 17:28
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$28,750
+5,000 vol
$5.75 each
20,670
Filed 2022-03-30 17:27
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,223
+1,200 vol
$6.02 each
15,670
Filed 2022-03-30 17:26
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,100
+500 vol
$6.20 each
14,470
Filed 2022-03-30 17:22
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,898
+2,600 vol
$5.73 each
Filed 2022-03-30 17:22
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,018
+700 vol
$5.74 each
Filed 2022-03-30 17:22
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$28,750
+5,000 vol
$5.75 each
Filed 2022-03-30 17:21
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$7,223
+1,200 vol
$6.02 each
Filed 2022-03-30 17:20
Tx date 2022-03-30
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,100
+500 vol
$6.20 each
Filed 2022-02-17 16:07
Tx date 2022-02-16
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,064
+3,150 vol
$5.10 each
32,384
Filed 2022-02-14 13:40
Tx date 2022-02-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,604
+300 vol
$5.35 each
29,234
Filed 2022-02-14 13:39
Tx date 2022-02-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,582
+300 vol
$5.28 each
28,934
Filed 2022-02-10 01:54
Tx date 2022-02-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,609
+300 vol
$5.37 each
28,634
Filed 2022-02-10 01:53
Tx date 2022-02-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,508
+835 vol
$5.40 each
28,334
Filed 2022-02-10 01:53
Tx date 2022-02-09
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,967
+365 vol
$5.39 each
27,499
Filed 2022-02-10 01:43
Tx date 2022-02-09
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,495
+2,700 vol
$6.85 each
10,445
Filed 2022-02-10 01:41
Tx date 2022-02-09
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,052
+300 vol
$6.84 each
7,745
Filed 2022-01-17 18:46
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
$50,000
Filed 2022-01-17 17:26
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
McConn, Brad
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
42,000
Filed 2022-01-17 17:15
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
40,000
Filed 2022-01-17 17:10
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Holder: Republique Capital (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
13,970
Filed 2022-01-17 17:09
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Chabot, Frederic
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
7,445
Filed 2022-01-17 10:00
Tx date 2022-01-13
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$124,500
+15,000 vol
$8.30 each
105,000
Filed 2022-01-13 12:36
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$397,000
+50,000 vol
$7.94 each
65,000
Filed 2022-01-13 12:35
Tx date 2021-06-02
$IPA
ImmunoPrecise Antibodies Ltd.
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
15,000
Filed 2022-01-12 00:42
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$198,500
+25,000 vol
$7.94 each
27,000
Filed 2022-01-12 00:35
Tx date 2022-01-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$952,800
+120,000 vol
$7.94 each
540,000
Filed 2022-01-12 00:18
Tx date 2022-01-11
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,497
+1,900 vol
$6.05 each
27,134
Filed 2021-12-31 17:21
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,647
+300 vol
$5.49 each
25,234
Filed 2021-12-31 17:20
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,977
+900 vol
$5.53 each
24,034
Filed 2021-12-31 17:19
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,959
+900 vol
$5.51 each
24,934
Filed 2021-12-31 17:19
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,647
+300 vol
$5.49 each
Filed 2021-12-31 17:16
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,647
+300 vol
$5.49 each
Filed 2021-12-31 17:15
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,959
+900 vol
$5.51 each
Filed 2021-12-31 17:15
Tx date 2021-12-30
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,977
+900 vol
$5.53 each
Filed 2021-12-29 18:00
Tx date 2021-12-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,190
+1,500 vol
$5.46 each
23,134
Filed 2021-12-29 18:00
Tx date 2021-12-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,249
+600 vol
$5.42 each
21,634
Filed 2021-12-29 17:59
Tx date 2021-12-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,635
+300 vol
$5.45 each
21,034
Filed 2021-12-29 17:57
Tx date 2021-12-29
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,629
+300 vol
$5.43 each
20,734
Filed 2021-12-21 20:06
Tx date 2021-12-20
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$30,000
+20,000 vol
$1.50 each
31,000
Filed 2021-12-21 20:05
Tx date 2021-12-20
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options
$-30,000
-20,000 vol
$1.50 each
45,000
Filed 2021-11-12 16:43
Tx date 2021-11-12
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$37,500
+25,000 vol
$1.50 each
25,000
Filed 2021-11-12 16:42
Tx date 2021-11-12
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options
$-37,500
-25,000 vol
$1.50 each
35,000
Filed 2021-10-22 11:28
Tx date 2021-10-19
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+20,000 vol
30,000
Filed 2021-10-22 11:27
Tx date 2021-10-19
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options

-20,000 vol
45,000
Filed 2021-08-30 20:53
Tx date 2021-08-26
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,758
+1,000 vol
$8.76 each
11,000
Filed 2021-08-11 08:20
Tx date 2021-08-06
$IPA
ImmunoPrecise Antibodies Ltd.
Dahl, Carla Cherry
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$413,550
+45,000 vol
$9.19 each
45,000
Filed 2021-08-11 08:18
Tx date 2021-08-02
$IPA
ImmunoPrecise Antibodies Ltd.
Dahl, Carla Cherry
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-10 17:03
Tx date 2021-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
500
Filed 2021-08-10 17:03
Tx date 2021-08-01
$IPA
ImmunoPrecise Antibodies Ltd.
Duplantis, Barry Neil
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
2,000
Filed 2021-07-14 14:58
Tx date 2021-07-14
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,459
+2,000 vol
$5.73 each
20,434
Filed 2021-07-12 11:20
Tx date 2021-07-12
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,550
+1,000 vol
$6.55 each
251,040
Filed 2021-07-09 15:35
Tx date 2021-07-09
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,820
+1,000 vol
$6.82 each
250,040
Filed 2021-06-09 10:51
Tx date 2021-06-09
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,000
+1,000 vol
$8.00 each
249,040
Filed 2021-05-18 23:09
Tx date 2021-05-18
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,805
+200 vol
$9.03 each
248,040
Filed 2021-05-13 15:30
Tx date 2021-05-13
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,000
+2,000 vol
$9.50 each
10,000
Filed 2021-05-12 18:51
Tx date 2021-05-12
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$64,260
+9,000 vol
$7.14 each
18,434
Filed 2021-03-16 11:30
Tx date 2021-03-16
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,071
+300 vol
$13.57 each
247,840
Filed 2021-03-11 15:45
Tx date 2021-03-11
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,425
+300 vol
$14.75 each
247,540
Filed 2021-01-25 09:48
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Abdiche, Yasmina Noubia
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-200,000 vol
50,000
Filed 2021-01-25 08:14
Tx date 2020-04-01
$IPA
ImmunoPrecise Antibodies Ltd.
Abdiche, Yasmina Noubia
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2021-01-12 07:16
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-120,000 vol
30,000
Filed 2021-01-12 07:15
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Convertible Debentures
37 - Stock split or consolidation

-$68,000 vol
$17,000
Filed 2021-01-12 07:14
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Direct Ownership
Convertible Debentures
37 - Stock split or consolidation

-$115,200 vol
$28,800
Filed 2021-01-12 07:13
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-988,960 vol
247,240
Filed 2021-01-12 07:09
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Holder: Brisio Innovations Inc. (Control or Direction)
Common Shares
37 - Stock split or consolidation

-2,240,000 vol
560,000
Filed 2021-01-12 07:07
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,717,440 vol
429,360
Filed 2021-01-08 11:02
Tx date 2021-01-06
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options

+5,000 vol
65,000
Filed 2021-01-08 11:01
Tx date 2021-01-06
$IPA
ImmunoPrecise Antibodies Ltd.
Lundstrom, Brian
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options

+5,000 vol
35,000
Filed 2021-01-08 11:00
Tx date 2021-01-06
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options

+5,000 vol
65,000
Filed 2021-01-08 10:58
Tx date 2021-01-06
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options

+5,000 vol
60,000
Filed 2021-01-08 10:47
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-240,000 vol
60,000
Filed 2021-01-08 10:46
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Holder: Kari Ridd (Control or Direction)
Common Shares
37 - Stock split or consolidation

-4,000 vol
1,000
Filed 2021-01-08 10:45
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Smith, Gregory Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-40,000 vol
10,000
Filed 2021-01-08 10:40
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Lundstrom, Brian
4 - Director of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-120,000 vol
30,000
Filed 2021-01-08 10:38
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Lundstrom, Brian
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-55,200 vol
13,800
Filed 2021-01-08 10:35
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-280,000 vol
70,000
Filed 2021-01-08 10:34
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-8,000 vol
2,000
Filed 2021-01-08 10:31
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-220,000 vol
55,000
Filed 2021-01-08 10:27
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-240,000 vol
60,000
Filed 2021-01-08 10:26
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Holder: Elizabeth Grant (Control or Direction)
Common Shares
37 - Stock split or consolidation

-34,400 vol
8,600
Filed 2021-01-08 10:25
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Burke, Robert
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-32,000 vol
8,000
Filed 2021-01-08 10:25
Tx date 2021-01-06
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$101,500
+5,000 vol
$20.30 each
155,000
Filed 2021-01-08 10:23
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
37 - Stock split or consolidation

-$140,000 vol
$35,000
Filed 2021-01-08 10:22
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-1,680,000 vol
420,000
Filed 2021-01-08 10:21
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-37,735 vol
9,434
Filed 2021-01-08 10:19
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
37 - Stock split or consolidation

-360,000 vol
90,000
Filed 2021-01-08 10:18
Tx date 2020-11-23
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-8,000 vol
2,000
Filed 2020-10-28 12:42
Tx date 2020-10-28
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$10,476
+5,400 vol
$1.94 each
1,236,200
Filed 2020-10-22 18:00
Tx date 2020-10-22
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,656
+3,200 vol
$2.08 each
1,230,800
Filed 2020-09-25 08:32
Tx date 2020-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Brisio Innovations Inc. (Control or Direction)
Common Shares
54 - Exercise of warrants
$312,500
+250,000 vol
$1.25 each
2,800,000
Filed 2020-09-25 08:27
Tx date 2020-09-23
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Brisio Innovations Inc. (Control or Direction)
Warrants
54 - Exercise of warrants
$-312,500
-250,000 vol
$1.25 each
0
Filed 2020-09-18 17:39
Tx date 2020-09-16
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-139,989.36
-72,100 vol
$1.94 each
1,576,000
Filed 2020-09-18 17:38
Tx date 2020-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-557,647.09
-271,150 vol
$2.06 each
1,648,100
Filed 2020-09-18 17:36
Tx date 2020-09-14
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-113,732.675
-56,750 vol
$2.00 each
1,919,250
Filed 2020-09-18 17:34
Tx date 2020-09-16
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-139,989.36
-72,100 vol
$1.94 each
932,000
Filed 2020-09-18 17:31
Tx date 2020-09-15
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-557,647.09
-271,150 vol
$2.06 each
1,004,100
Filed 2020-09-18 17:27
Tx date 2020-09-14
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-113,732.675
-56,750 vol
$2.00 each
1,275,250
Filed 2020-09-17 22:27
Tx date 2020-09-17
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$62,500
+50,000 vol
$1.25 each
1,227,600
Filed 2020-09-17 22:25
Tx date 2020-09-17
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-62,500
-50,000 vol
$1.25 each
0
Filed 2020-09-17 22:23
Tx date 2020-09-17
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$50,000
+40,000 vol
$1.25 each
2,146,800
Filed 2020-09-17 22:20
Tx date 2020-09-17
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-50,000
-40,000 vol
$1.25 each
0
Filed 2020-09-14 20:45
Tx date 2020-09-11
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Serenga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-221,400.43
-116,834 vol
$1.90 each
820,000
Filed 2020-09-14 20:45
Tx date 2020-09-10
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Serenga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-470,683.227
-253,806 vol
$1.85 each
936,834
Filed 2020-09-14 20:44
Tx date 2020-09-09
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Serenga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-583,638.576
-309,360 vol
$1.89 each
1,190,640
Filed 2020-09-14 20:36
Tx date 2020-09-11
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-54,733.285
-28,883 vol
$1.90 each
1,976,000
Filed 2020-09-14 20:35
Tx date 2020-09-10
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-116,271.5865
-62,697 vol
$1.85 each
2,004,883
Filed 2020-09-14 20:34
Tx date 2020-09-09
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-144,173.972
-76,420 vol
$1.89 each
2,067,580
Filed 2020-09-14 20:33
Tx date 2020-09-11
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-54,733.285
-28,883 vol
$1.90 each
1,332,000
Filed 2020-09-14 20:33
Tx date 2020-09-10
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-116,271.5865
-62,697 vol
$1.85 each
1,360,883
Filed 2020-09-14 20:32
Tx date 2020-09-09
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Topanga OU (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-144,173.972
-76,420 vol
$1.89 each
1,423,580
Filed 2020-09-06 01:15
Tx date 2020-09-03
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$62,500
+50,000 vol
$1.25 each
2,106,800
Filed 2020-09-06 01:11
Tx date 2020-09-03
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-62,500
-50,000 vol
$1.25 each
40,000
Filed 2020-09-02 14:56
Tx date 2020-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$170,000
+100,000 vol
$1.70 each
350,000
Filed 2020-09-02 14:53
Tx date 2020-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$255,000
+150,000 vol
$1.70 each
450,000
Filed 2020-09-02 14:50
Tx date 2020-09-01
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Options Stock Options
50 - Grant of options
$1,785,000
+1,050,000 vol
$1.70 each
2,100,000
Filed 2020-08-24 19:32
Tx date 2020-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-35,000
-25,000 vol
$1.40 each
0
Filed 2020-08-20 12:19
Tx date 2020-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$7,500
+25,000 vol
$0.30 each
25,000
Filed 2020-08-20 12:18
Tx date 2020-08-17
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Options Stock Options
51 - Exercise of options
$-7,500
-25,000 vol
$0.30 each
275,000
Filed 2020-08-19 18:57
Tx date 2016-12-29
$IPA
ImmunoPrecise Antibodies Ltd.
Kuo, James
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-31 19:27
Tx date 2020-07-30
$IPA
ImmunoPrecise Antibodies Ltd.
Lang, Stefan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,230
+3,000 vol
$1.41 each
10,000
Filed 2020-07-08 12:06
Tx date 2020-07-08
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,300
+10,000 vol
$1.23 each
2,056,800
Filed 2020-06-19 14:17
Tx date 2020-06-18
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$295,000
+295,000 vol
$1.00 each
2,046,800
Filed 2020-06-19 14:16
Tx date 2020-06-18
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-295,000
-295,000 vol
$1.00 each
90,000
Filed 2020-06-17 12:50
Tx date 2020-06-16
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$62,500
+62,500 vol
$1.00 each
2,144,000
Filed 2020-06-17 12:48
Tx date 2020-06-16
$IPA
ImmunoPrecise Antibodies Ltd.
Malberg, Miko
3 - 10% Security Holder of Issuer
Holder: Kokkuhoideur OU (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-62,500
-62,500 vol
$1.00 each
1,750,000
Filed 2020-05-20 17:52
Tx date 2020-05-15
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$175,000 vol
$0.85 each
$175,000
Filed 2020-05-20 17:38
Tx date 2020-05-15
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$85,000 vol
$0.85 each
$85,000
Filed 2020-05-20 17:34
Tx date 2020-05-15
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$144,000 vol
$0.85 each
$144,000
Filed 2020-05-19 18:51
Tx date 2018-11-20
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Holder: Patricia Finlayson (Indirect Ownership)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 18:47
Tx date 2018-11-20
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-19 17:56
Tx date 2018-02-08
$IPA
ImmunoPrecise Antibodies Ltd.
Bath, Jennifer Lynne
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-13 10:49
Tx date 2020-05-13
$IPA
ImmunoPrecise Antibodies Ltd.
Andreola, Gianpaolo Fabrisio
4 - Director of Issuer
Direct Ownership